Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4 Suppl
pubmed:dateCreated
2000-11-8
pubmed:abstractText
Recently a novel topical nail lacquer, ciclopirox solution 8%, has been approved for the treatment of onychomycosis.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0190-9622
pubmed:author
pubmed:issnType
Print
pubmed:volume
43
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
S81-95
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:11051137-Administration, Oral, pubmed-meshheading:11051137-Administration, Topical, pubmed-meshheading:11051137-Antifungal Agents, pubmed-meshheading:11051137-Arthrodermataceae, pubmed-meshheading:11051137-Costs and Cost Analysis, pubmed-meshheading:11051137-Drug Costs, pubmed-meshheading:11051137-Economics, Pharmaceutical, pubmed-meshheading:11051137-Female, pubmed-meshheading:11051137-Fluconazole, pubmed-meshheading:11051137-Foot Dermatoses, pubmed-meshheading:11051137-Griseofulvin, pubmed-meshheading:11051137-Humans, pubmed-meshheading:11051137-Itraconazole, pubmed-meshheading:11051137-Male, pubmed-meshheading:11051137-Models, Economic, pubmed-meshheading:11051137-Naphthalenes, pubmed-meshheading:11051137-Onychomycosis, pubmed-meshheading:11051137-Pyridones, pubmed-meshheading:11051137-Randomized Controlled Trials as Topic, pubmed-meshheading:11051137-United States
pubmed:year
2000
pubmed:articleTitle
Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States.
pubmed:affiliation
Department of Medicine, Sunnybrook and Women's College Health Sciences Center, and University of Toronto, Ontario, Canada.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't, Meta-Analysis